top of page


Galderma's $1.5bn ZO Deal Buys 16,500 Doctors, Not a Formula
Galderma signed a US$1.5bn all-cash deal for ZO Skin Health on October 14, 2026. The asset is 16,500 physician accounts, not a patent.
Oct 197 min read


Luxury Beauty Didn't Fail on Science. It Failed Without a Licence.
L’Oréal and Galderma’s 2026 data shows that growth in prestige beauty is driven not by formulas or luxury marketing, but by licensed intermediaries like dermatologists, prescribers, and salon professionals. While luxury skincare recovers slowly, prescription and professional categories are surging—a trend amplified by GLP-1 treatments and supply chain strength in Korean pharma and manufacturers.
Oct 26 min read
bottom of page